CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles and their coatings for R&D and commercialization in a wide variety of application areas including in-vitro diagnostics, biochemistry, cellular analysis, cell separation, immunoassay. As a global supplier, our experienced technical teams provide high quality products, including magnetic particles, gold nanoparticles, silica particles, polymer particles, quantum dots, beads based conjugation kit, magnetic separation kit, etc., and provide services specifically tailored for in vitro and in vivo assay development and research. We can offer various custom services including chemical surface-functionalized, fluorescent modification, antibody immobilization, nucleic acid and oligo conjugation to meet clients’ specifications.
Atualizações Recentes
- CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted DeliveryCD Bioparticles announces its expanded capabilities in Customized Liposomes. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is proud to announce its expanded capabilities in Customized Liposomes. This advancement allows researchers and developers to leverage the power of liposome technology for a wider range of applications. Liposomes...0 Comentários 0 Compartilhamentos 13 Visualizações 0 AnteriorFaça Login para curtir, compartilhar e comentar!
- CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex ParticlesCD Bioparticles announces its advanced line of multiplex fluorescence particles. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side...0 Comentários 0 Compartilhamentos 12 Visualizações 0 Anterior
- CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug DeliveryCD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers for a variety of drug delivery applications. These polymers offer tunable physicochemical...0 Comentários 0 Compartilhamentos 250 Visualizações 0 Anterior
- CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and PurificationCD Bioparticles announces the launch of its new line of Conjugated Agarose Particles for researchers. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is excited to announce the launch of its new line of Conjugated Agarose Particles with various particle sizes (45-500 µm), designed to streamline protein purification workflows for...0 Comentários 0 Compartilhamentos 251 Visualizações 0 Anterior
- CD BIOPARTICLES ANNOUNCES NEW LINE OF POLYACRYLAMIDES FOR DRUG DELIVERY STUDIESCD Bioparticles is proud to announce the launch of its Polyacrylamides. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, announced the launch of its expanded line of low-PDI polymers, Polyacrylamides. The new product line offers different functional groups (e.g., acid, amine, and methoxy) and a variety of molecular weights (1.5 KDa-6,000...0 Comentários 0 Compartilhamentos 500 Visualizações 0 Anterior
- CD BIOPARTICLES INTRODUCES INNOVATIVE AGAROSE PARTICLES FOR PURIFICATION OF PROTEINS AND ANTIBODIESCD Bioparticles proudly announces the launch of its Agarose Particles for isolation and purification of proteins and antibodies. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles proudly announces the launch of its latest product line of Agarose Particles for isolation and purification of proteins and antibodies. These versatile microspheres,...0 Comentários 0 Compartilhamentos 454 Visualizações 0 Anterior
- CD BIOPARTICLES LAUNCHES NEW RANGE OF LOW PDI POLYMERS FOR DRUG DELIVERY APPLICATIONSCD Bioparticles announces the launch of a new range of Low PDI Polymers. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is thrilled to announce the launch of its latest innovation in the field of polymers, a new range of Low PDI Polymers. These cutting-edge polymers are specifically designed to deliver enhanced performance in various...0 Comentários 0 Compartilhamentos 593 Visualizações 0 Anterior
- CD BIOPARTICLES LAUNCHES NEW LINE OF PARTICLES FOR SOLID PHASE ORGANIC SYNTHESISCD Bioparticles has announced the expanded portfolio of its new Particles for Solid Phase Organic Synthesis. With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expanded portfolio of its new Particles for Solid Phase Organic Synthesis, including functional resins, preloaded resins and resins for special synthesis, providing a more...0 Comentários 0 Compartilhamentos 576 Visualizações 0 Anterior
- PLGA Nano Drug CarrierPoly(lactic-co-glycolic acid) (PLGA) is a functional polymer organic compound randomly polymerized by lactic acid (PLA) and glycolic acid (PGA). It has been approved by the U.S. Food and Drug Administration It is certified by the Food and Drug Administration (FDA) and is a copolymer material available on the market. PLGA has good biocompatibility, biodegradability, mechanical strength, good...0 Comentários 0 Compartilhamentos 651 Visualizações 0 Anterior
- Colored Polystyrene Particles in Developing Rapid and Affordable Point-of-Care DiagnosticsWhat is POCT? Multiplexed point-of-care testing POCT (Point-of-Care Testing) refers to clinical and bedside testing conducted in close proximity to patients. It is often not performed by clinical laboratory personnel. POCT holds significant importance in disease prevention, etiology determination, prognosis, enhancing treatment outcomes, and reducing healthcare expenses. It meets clinical...0 Comentários 0 Compartilhamentos 791 Visualizações 0 Anterior
Mais Stories